ClosedPublished 23 Sep 2026
Zymeworks Inc. /
Theravance Biopharma, Inc.
Zymeworks Inc. completed its deal for Theravance Biopharma, Inc.




01 / BuyerZymeworks Inc.
02 / TargetTheravance Biopharma, Inc.
Source for the buyer and target: Theravance Biopharma, Inc.
For the buyer and target.
buyer
“Capitalized terms used but not defined herein shall have the meaning given in that certain Agreement and Plan of Merger, dated as of June 28, 2026 (as such agreement may be amended, restated or otherwise modified from time to time) (the “ Merger Agreement ”), by and among the Company, Zymeworks, Inc. and Zymeworks Merger Sub 1.”
target
“Amended and Restated Memorandum and Articles of Association of Theravance Biopharma, Inc.”
Published 23 Sep 2026
Open the sourceWhat happened
The deal for Theravance Biopharma, Inc. has closed, with Zymeworks Inc. as the buyer. [01]
The filing from Theravance Biopharma, Inc. is dated Sept. 23, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Theravance Biopharma, Inc.
Zymeworks Inc. completed its deal for Theravance Biopharma, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly